Hims & Hers shares plummet 35% as Novo Nordisk pulls partnership plug
Pharmaceutical Technology
JUNE 24, 2025
Robert Barrie June 24, 2025 Share Copy Link Share on X Share on Linkedin Share on Facebook Compounded GLP-1RA medication has become a key revenue driver for Hims & Hers’ telehealth platform. Hims & Hers’ revenue has been soaring on the back of its compounded glucagon-like peptide-1 receptor agonist (GLP-1RA) sales.
Let's personalize your content